Chirag Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Chirag Patel has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Sameer Al Diffalha
University of Alabama at Birmingham
2 shared publications Alyssa K. McGary
Mayo Clinic Arizona
1 shared publication- Brendan M. McGuire
Division of Gastroenterology and Hepatology, Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA
1 shared publication - Darren Salmi
Stanford University, Stanford, California, United States
1 shared publication - Deepti Dhall
Department of Pathology, The University of Alabama at Birmingham, Alabama
1 shared publication - Goo Lee
Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama
1 shared publication
Latest Publications
- 11 June 2025
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 34 (1) , 12-22
Artificial Intelligence Quantitation of Steatosis on Frozen Section Preimplant Slides Correlates with Some Liver Transplant Outcomes
Introduction.: Increased steatosis on preimplant liver frozen section is associated with delayed graft function and primary nonfunction. Efforts to standardize histologic assessment have proven difficult. Frozen section artifact and lipopeliosis complicate the detection of steatosis. We aimed to develop and validate an AI model to recognize large droplet fat and fat induced artifact (FIA)/lipopeliosis on preimplantation frozen section and to correlate the AI results with post-transplant clinical parameters. Methods.: The model was applied to 161 consecutive liver transplant specimens with preimplant slides. Results were correlated with traditional and Banff histologic assessment and clinical parameters. Results.: By traditional assessment, steatosis ranged from 0%–40%. The AI model identified a range of 0 to 15.9% steatosis. There was no difference in patient survival by any measures of steatosis. AI steatosis correlated with increased risk of early allograft dysfunction (OR = 1.63, P < .001), respiratory failure (OR = 1.21, P = .003), and more advanced fibrosis (OR = 1.18, P = .030), but was not correlated with graft or patient survival. FIA/lipopeliosis were identified in a range of 0 to 6.42%. In univariate analysis the percentage of FIA/lipopeliosis correlated with both graft and patient survival ( P = .044 and P = .009, respectively), but was not associated with increased risk of early allograft dysfunction, respiratory failure, or advanced fibrosis. Conclusions.: We developed an AI model that quantitates large droplet fat and FIA/lipopeliosis on frozen section slides and found a correlation with post-transplant outcomes. Further studies on larger, multi-institutional cohorts with higher fat containing donors are necessary to determine the role this model may have in organ acceptance decisions.
- 11 June 2025
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 34 (1) , 12-22
Artificial Intelligence Quantitation of Steatosis on Frozen Section Preimplant Slides Correlates with Some Liver Transplant Outcomes
Introduction.: Increased steatosis on preimplant liver frozen section is associated with delayed graft function and primary nonfunction. Efforts to standardize histologic assessment have proven difficult. Frozen section artifact and lipopeliosis complicate the detection of steatosis. We aimed to develop and validate an AI model to recognize large droplet fat and fat induced artifact (FIA)/lipopeliosis on preimplantation frozen section and to correlate the AI results with post-transplant clinical parameters. Methods.: The model was applied to 161 consecutive liver transplant specimens with preimplant slides. Results were correlated with traditional and Banff histologic assessment and clinical parameters. Results.: By traditional assessment, steatosis ranged from 0%–40%. The AI model identified a range of 0 to 15.9% steatosis. There was no difference in patient survival by any measures of steatosis. AI steatosis correlated with increased risk of early allograft dysfunction (OR = 1.63, P < .001), respiratory failure (OR = 1.21, P = .003), and more advanced fibrosis (OR = 1.18, P = .030), but was not correlated with graft or patient survival. FIA/lipopeliosis were identified in a range of 0 to 6.42%. In univariate analysis the percentage of FIA/lipopeliosis correlated with both graft and patient survival ( P = .044 and P = .009, respectively), but was not associated with increased risk of early allograft dysfunction, respiratory failure, or advanced fibrosis. Conclusions.: We developed an AI model that quantitates large droplet fat and FIA/lipopeliosis on frozen section slides and found a correlation with post-transplant outcomes. Further studies on larger, multi-institutional cohorts with higher fat containing donors are necessary to determine the role this model may have in organ acceptance decisions.
- Open Access
- 31 July 2023
- Published by Wiley in Case Reports in Hepatology
- Vol. 2023, 1-5
CALFAN (Low γ-Glutamyl Transpeptidase (GGT) Cholestasis, Acute Liver Failure, and Neurodegeneration) Syndrome: A Case Report with 3-Year Follow-Up after Liver Transplantation in Early Adulthood
CALFAN syndrome is an extremely rare disease consisting of recurrent pediatric acute liver failure (PALF), neurodegenerative diseases, and skeletal abnormalities associated with SCYL1 gene mutation. To date, three of 18 patients reported underwent liver transplantation in infancy and early childhood (723months). Here, we report a case of CALFAN syndrome with infantile onset, recurrent jaundice/PALF requiring liver transplantation in early adulthood. At the most recent follow-up, 3years after transplantation, the patient is doing well.
- 31 July 2023
- Published by Wiley in Case Reports in Hepatology
- Vol. 2023, 1-5
Open AccessCALFAN (Low γ-Glutamyl Transpeptidase (GGT) Cholestasis, Acute Liver Failure, and Neurodegeneration) Syndrome: A Case Report with 3-Year Follow-Up after Liver Transplantation in Early Adulthood
CALFAN syndrome is an extremely rare disease consisting of recurrent pediatric acute liver failure (PALF), neurodegenerative diseases, and skeletal abnormalities associated with SCYL1 gene mutation. To date, three of 18 patients reported underwent liver transplantation in infancy and early childhood (723months). Here, we report a case of CALFAN syndrome with infantile onset, recurrent jaundice/PALF requiring liver transplantation in early adulthood. At the most recent follow-up, 3years after transplantation, the patient is doing well.
- Open Access
- 21 August 2020
- Published by Taylor & Francis in Hepatic Oncology
- Vol. 8 (1) , HEP28
Cirrhotomimetic hepatocellular carcinoma: experience of a single institution and review of the literature
Cirrhotomimetic hepatocellular carcinoma is a recognized pattern exhibiting cirrhosis-like growth and a reputation for evading pretransplant detection. Five cases encountered from our institution w...
- 21 August 2020
- Published by Taylor & Francis in Hepatic Oncology
- Vol. 8 (1) , HEP28
Open AccessCirrhotomimetic hepatocellular carcinoma: experience of a single institution and review of the literature
Cirrhotomimetic hepatocellular carcinoma is a recognized pattern exhibiting cirrhosis-like growth and a reputation for evading pretransplant detection. Five cases encountered from our institution w...
- 25 June 2010
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 55 (2) , 361-363
Neuroblastoma of unknown primary site with periorbital bone metastasis in a child
Neuroblastoma is the second most common solid tumor in children. Most tumors arise in the adrenal glands or paravertebral region. Rarely, patients present with metastatic disease but no primary site can be found despite extensive imaging. We report here a patient with a large periorbital bone metastasis and bone marrow involvement but with no known primary site. Pediatr Blood Cancer.
- 25 June 2010
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 55 (2) , 361-363
Neuroblastoma of unknown primary site with periorbital bone metastasis in a child
Neuroblastoma is the second most common solid tumor in children. Most tumors arise in the adrenal glands or paravertebral region. Rarely, patients present with metastatic disease but no primary site can be found despite extensive imaging. We report here a patient with a large periorbital bone metastasis and bone marrow involvement but with no known primary site. Pediatr Blood Cancer.